Jefferies Financial Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-63,359
Closed -$410K 1311
2025
Q1
$410K Sell
63,359
-386,641
-86% -$2.78M ﹤0.01% 1113
2024
Q4
$3.63M Buy
450,000
+50,000
+13% +$412K 0.02% 465
2024
Q3
$3.26M Buy
400,000
+50,000
+14% +$330K 0.02% 434
2024
Q2
$2.44M Buy
350,000
+303,400
+651% +$2.3M 0.03% 483
2024
Q1
$494K Sell
46,600
-253,400
-84% -$2.22M ﹤0.01% 1066
2023
Q4
$2.41M Sell
300,000
-200,000
-40% -$1.46M 0.02% 641
2023
Q3
$4.11M Sell
500,000
-3,000,000
-86% -$25.9M 0.04% 390
2023
Q2
$28M Sell
3,500,000
-1,850,000
-35% -$13.6M 0.25% 69
2023
Q1
$43.3M Buy
5,350,000
+4,443,942
+490% +$35.7M 0.35% 44
2022
Q4
$5.69M Buy
+906,058
New +$6.33M 0.04% 368

Other funds holding BHC

Jefferies Financial Group's BHC Position: Q2 2025 in Review

Jefferies Financial Group sold out of Bausch Health (BHC) in Q2 2025, closing a stake of 63,359 shares — an estimated $410K sold.

Jefferies Financial Group first reported a position in BHC in Q4 2022 and held it in 10 quarters. The position peaked at $43.3M in Q1 2023. 212 funds tracked by Wall St. Rank hold BHC as of Q2 2025.

  • Jefferies Financial Group reported no remaining Bausch Health position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 63,359 Bausch Health shares in Q2 2025, an estimated $410K.
  • Jefferies Financial Group first reported a position in Bausch Health in Q4 2022 and held it in 10 quarters.
  • Jefferies Financial Group's Bausch Health position peaked at $43.3M in Q1 2023.
  • 212 funds tracked by Wall St. Rank held Bausch Health as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.